CCM
FURX

Camber Capital Management’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

Camber Capital Management’s Portfolio FURX Stock Details FURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-200,000
Closed -$21.2M – 49
2014
Q2 		$21.2M Buy
200,000
+50,000
+33% +$4.9M 1.39% 25
2014
Q1 		$13.1M Buy
+150,000
New +$11.6M 1.02% 25

Camber Capital Management's FURX Position: Q3 2014 in Review

Camber Capital Management sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q3 2014, closing a stake of 200,000 shares — an estimated $21.2M sold.

Camber Capital Management first reported a position in FURX in Q1 2014 and held it in 2 quarters. The position peaked at $21.2M in Q2 2014. 0 funds tracked by Wall St. Rank hold FURX as of Q3 2014.

  • Camber Capital Management reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • Camber Capital Management sold 200,000 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $21.2M.
  • Camber Capital Management first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q1 2014 and held it in 2 quarters.
  • Camber Capital Management's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $21.2M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on Camber Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.